Biogen Inc
DUS:IDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
DUS:IDP
|
US |
|
O
|
Origin Bancorp Inc
F:36Z
|
US |
|
A
|
Asahi Intecc Co Ltd
F:6XT
|
JP |
|
ING Groep NV
AEX:INGA
|
NL |
|
Hong Kong and China Gas Co Ltd
F:HCG
|
HK |
|
R
|
RH
BMV:RH
|
US |
|
U
|
USANA Health Sciences Inc
SWB:USJ
|
US |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
A
|
AES Corp
XBER:AES
|
US |
|
N
|
Northrop Grumman Corp
DUS:NTH
|
US |
|
Aehr Test Systems
NASDAQ:AEHR
|
US |
|
Banco de Sabadell SA
MAD:SAB
|
ES |
|
U
|
Ulta Beauty Inc
XMUN:34U
|
US |
|
Philip Morris International Inc
NYSE:PM
|
US |
|
P
|
Pitney Bowes Inc
F:PBW
|
US |
|
D
|
Discover Financial Services
XMUN:DC7
|
US |
|
B
|
Bilfinger SE
XBER:GBF
|
DE |
|
S
|
Siemens Energy AG
XMUN:ENR
|
DE |
|
S
|
SDIC Power Holdings Co Ltd
LSE:SDIC
|
CN |
|
M
|
MINISO Group Holding Ltd
HKEX:9896
|
CN |
|
G
|
Gilead Sciences Inc
XMUN:GIS
|
US |
|
A
|
Altria Group Inc
BMV:MO
|
US |
|
Swisscom AG
SIX:SCMN
|
CH |
|
A
|
Advtech Ltd
JSE:ADH
|
ZA |
Bankruptcy Probability
Biogen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biogen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
30.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
198.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biogen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biogen Inc has total debt of 6.3B USD. This includes both short-term (0 USD) and long-term (6.3B USD) debt.
You can find a full breakdown on its Balance Sheet.
